Page last updated: 2024-08-17

methylene blue and Liver Steatosis

methylene blue has been researched along with Liver Steatosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, YH; Kim, SG; Kim, TH; Shin, SY; Wu, H1
Haym, J; Schmidt, D1

Other Studies

2 other study(ies) available for methylene blue and Liver Steatosis

ArticleYear
SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis.
    European journal of pharmacology, 2014, Mar-15, Volume: 727

    Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; DNA, Mitochondrial; Dose-Response Relationship, Drug; Drug Repositioning; Energy Metabolism; Enzyme Activation; Enzyme Activators; Fatty Liver; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Male; Methylene Blue; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial Turnover; NAD; Rats; RNA Interference; Sirtuin 1; Time Factors; Transfection

2014
[On the problem of a selective thermosensitization of carcinoma cells in vivo with vitamin K3-sodium bisulfite, methylene blue and other thermosensitizators. 1. On the toxicology of vitamin K3-sodium bisulfite in combination with methylene blue on rats an
    Arzneimittel-Forschung, 1968, Volume: 18, Issue:6

    Topics: Animals; Carcinoma, Ehrlich Tumor; Dogs; Fatty Liver; Female; Fever; Hemorrhage; Male; Methylene Blue; Mice; Necrosis; Nephrosis; Rats; Sodium; Species Specificity; Sulfites; Vitamin K

1968